MEDx Translational Medicine Co.、Ltd

Manufacturer
China
www.MEDxTMC.cn/www.MEDxTMC.com
MARKETING@MEDxTMC.com
400 007 1121

MEDx Translational Medicine Co., Ltd (simply MEDx) was founded in 2013, formerly known as the Translational Medicine Research Center of QIAGEN China. As the leader of Companion Diagnostics Total-Solution Providers, MEDx can provide comprehensive translational medicine technology support for clinical transformation of drugs, companion diagnostics (CDx) development and Clinical testing for Precision Medicine. Taking advantage of comprehensive translational platforms including genomics, proteomics, cytomics, pathology, big data and AI, first-class product development team, perfect R&D process, and high quality system (CAP, ISO13485, CNAS/ ISO17025, GMP and GSP), MEDx enables drugs clinical translation research and develops CDx products to support targeted therapy, immunotherapy and cell/gene therapy. MEDx has cooperated with 300+ innovative pharmaceutical companies and technology companies around the world, developed and verified hundreds of biomarkers and methodologies, and supported hundreds of drug clinical trials. Up to now, there are more than 20 products have been approved, including China's first approved JAK2-V617F mutation detection kit and PDL-1 detection kit for immunotherapy; and 8 products CE certified products and more than 10 other clinically needed products. At the same time, MEDx has more than 40 CDx/IVD product pipelines under research, of which 5 are in clinical trials. Based on the unique integrated business model, MEDx has become an innovative company in China for the total-solution of companion diagnostics.